Mangoceuticals (MGRX) Shares Outstanding (Weighted Average) (2022 - 2026)

Mangoceuticals has disclosed Shares Outstanding (Weighted Average) across 5 years of filings, most recently posting $16.5 million for Q1 2026.

• Shares Outstanding (Weighted Average) for Q1 2026 came in at $16.5 million, up 258.84% year-over-year; the trailing twelve-month figure through Mar 2026 was $16.5 million (up 258.84% YoY), and the FY2025 annual result was $10.1 million, up 408.93% from the prior year.
• Shares Outstanding (Weighted Average) came in at $16.5 million for Q1 2026 at Mangoceuticals, up from $10.1 million in the prior quarter.
• In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $16.5 million in Q1 2026 to a low of $997899.0 in Q3 2025.
• The 5-year median for Shares Outstanding (Weighted Average) is $3.3 million (2024), against an average of $6.1 million.
• Across the five-year window, Shares Outstanding (Weighted Average) slumped 90.05% in 2023 and jumped 408.93% in 2025, its largest moves.
• Mangoceuticals' Shares Outstanding (Weighted Average) stood at $10.8 million in 2022, then plunged by 90.05% to $1.1 million in 2023, then surged by 84.23% to $2.0 million in 2024, then surged by 408.93% to $10.1 million in 2025, then jumped by 63.64% to $16.5 million in 2026.
• The last three Shares Outstanding (Weighted Average) figures came in at $16.5 million (Q1 2026), $10.1 million (Q4 2025), and $997899.0 (Q3 2025), per Business Quant data.